Home > Internet > Rumors, Lies Combined With Ibrutinib

Rumors, Lies Combined With Ibrutinib

Added: (Mon Jul 02 2018)

Pressbox (Press Release) - Relapses involved axial (24), extremity (10), or craniofacial bones (4). Treatment for recurrence included surgery (28), radiotherapy (10), and chemotherapy (27). After a median follow-up of 1.9 years (range: 0.1�C21.2) from first recurrence for all 38 patients and 5.5 years (0.3�C21.2) for 16 survivors (10 in continuous second CR), 2- and 5-year overall and event-free survival (EFS) probabilities were 55% and 34% and 34% and 27%, respectively. A long interval to recurrence (>1.5 years) predicted for better overall (P? Submitted by:

Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.